Dr. Rochelle Walensky has been a member of the Cost-effectiveness of Preventing AIDS Complications (CEPAC) team since 1998. She is a member of the Office of AIDS Research Advisory Council at the National Institutes of Health and the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Dr. Walensky has […]
HIV
While plan will target 48 “hot spots” with services, and people at high risks with PrEP, will it change policies that fuel HIV? More details are […]
Tuberculosis
With the release of a “pre-final text” of updated guidelines for treatment of multidrug- and rifampicin-resistant tuberculosis, the World Health Organization made official substantial changes to […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
Drawing on previously published findings and on-the-ground interviews, a report from Planned Parenthood details damage to global health gains, including in closed programs, weakened civil society, […]